Understanding mutational processes in human cancer

Mouse models of lung cancer

'Rewiring' tumour susceptibility

Deciphering RAS/MAPK signalling in cancer

Changing landscape of multiple myeloma care: Expert discussion

Cured AML patients generate anti-tumour antibodies that kill AML blasts

Very late relapse in Hodgkins lymphoma

Monitoring the cancer genome in plasma using circulating tumour DNA

Models and critical preclinical data shaping personal therapy

Cancer organoids

Serum miRNAs as diagnostic tools in GI malignancies

Combination trial designs: efficient, effective and tolerable regimens